BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 37483593)

  • 1. Efficacy and safety of innate and adaptive immunotherapy combined with standard of care in high-grade gliomas: a systematic review and meta-analysis.
    Guo B; Zhang S; Xu L; Sun J; Chan WL; Zheng P; Zhang J; Zhang L
    Front Immunol; 2023; 14():966696. PubMed ID: 37483593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Long-Term and Short-Term Efficacy of Immunotherapy in Non-Small Cell Lung Cancer Patients With Brain Metastases: A Systematic Review and Meta-Analysis.
    Chu X; Niu L; Xiao G; Peng H; Deng F; Liu Z; Wu H; Yang L; Tan Z; Li Z; Zhou R
    Front Immunol; 2022; 13():875488. PubMed ID: 35693805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain Metastases Status and Immunotherapy Efficacy in Advanced Lung Cancer: A Systematic Review and Meta-Analysis.
    Hu H; Xu ZY; Zhu Q; Liu X; Jiang SC; Zheng JH
    Front Immunol; 2021; 12():669398. PubMed ID: 34335570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-angiogenic therapy for high-grade glioma.
    Ameratunga M; Pavlakis N; Wheeler H; Grant R; Simes J; Khasraw M
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008218. PubMed ID: 30480778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of targeted therapy combined with radiotherapy and temozolomide-based chemotherapy in the treatment of glioma: A systemic review and meta-analysis of phase II/III randomized controlled trials.
    Ma Y; Wang Y; Nie C; Lin Y
    Front Oncol; 2023; 13():1082539. PubMed ID: 36776303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant Temozolomide Chemotherapy With or Without Interferon Alfa Among Patients With Newly Diagnosed High-grade Gliomas: A Randomized Clinical Trial.
    Guo C; Yang Q; Xu P; Deng M; Jiang T; Cai L; Li J; Sai K; Xi S; Ouyang H; Liu M; Li X; Li Z; Ni X; Cao X; Li C; Wu S; Du X; Su J; Xue X; Wang Y; Li G; Qin Z; Yang H; Zhou T; Liu J; Hu X; Wang J; Jiang X; Lin F; Zhang X; Ke C; Lv X; Lv Y; Hu W; Zeng J; Chen Z; Zhong S; Wang H; Chen Y; Zhang J; Li D; Mou Y; Chen Z
    JAMA Netw Open; 2023 Jan; 6(1):e2253285. PubMed ID: 36705923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of first-line immunotherapy plus chemotherapy in treating patients with extensive-stage small cell lung cancer: a Bayesian network meta-analysis.
    Zhang T; Li W; Diwu D; Chen L; Chen X; Wang H
    Front Immunol; 2023; 14():1197044. PubMed ID: 37435087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy of tumor antigen-pulsed DC treatment for high-grade glioma patients: evidence from a meta-analysis.
    Cao JX; Zhang XY; Liu JL; Li D; Li JL; Liu YS; Wang M; Xu BL; Wang HB; Wang ZX
    PLoS One; 2014; 9(9):e107173. PubMed ID: 25215607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The negative effect of antibiotics on RCC patients with immunotherapy: A systematic review and meta-analysis.
    Luo Z; Hao S; Li Y; Cheng L; Zhou X; Gunes EG; Liu S; Chen J
    Front Immunol; 2022; 13():1065004. PubMed ID: 36505435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Checkpoint inhibitors as dual immunotherapy in advanced non-small cell lung cancer: a meta-analysis.
    Alifu M; Tao M; Chen X; Chen J; Tang K; Tang Y
    Front Oncol; 2023; 13():1146905. PubMed ID: 37397392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiangiogenic therapy for high-grade glioma.
    Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
    Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage systemic therapy for advanced gastric and oesophago-gastric junction adenocarcinoma.
    Tomita Y; Moldovan M; Chang Lee R; Hsieh AH; Townsend A; Price T
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD012078. PubMed ID: 33210731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Vaccines After Conventional Treatments for Survival of Gliomas: A Systematic Review and Meta-Analysis.
    Amanzadeh Jajin E; Oraee Yazdani S; Zali A; Esmaeili A
    Oncol Rev; 2024; 18():1374513. PubMed ID: 38707486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and safety of anti-PD-1/PD-L1 in treatment of glioma: a single-arm meta-analysis.
    Zeng YF; Wei XY; Guo QH; Chen SY; Deng S; Liu ZZ; Gong ZC; Zeng WJ
    Front Immunol; 2023; 14():1168244. PubMed ID: 37122727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral infection and glioma: a meta-analysis of prognosis.
    Cai Z; Yang S; Li X; Chen F; Li W
    BMC Cancer; 2020 Jun; 20(1):549. PubMed ID: 32532243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effect of immunotherapy and standard therapy in patients with high grade glioma: a meta-analysis of published clinical trials.
    Artene SA; Turcu-Stiolica A; Ciurea ME; Folcuti C; Tataranu LG; Alexandru O; Purcaru OS; Tache DE; Boldeanu MV; Silosi C; Dricu A
    Sci Rep; 2018 Aug; 8(1):11800. PubMed ID: 30087385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis.
    Hanna C; Lawrie TA; Rogozińska E; Kernohan A; Jefferies S; Bulbeck H; Ali UM; Robinson T; Grant R
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013261. PubMed ID: 32202316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of the platelet to lymphocyte ratio (PLR) in the clinical outcomes of patients with advanced lung cancer receiving immunotherapy: A systematic review and meta-analysis.
    Zhou K; Cao J; Lin H; Liang L; Shen Z; Wang L; Peng Z; Mei J
    Front Oncol; 2022; 12():962173. PubMed ID: 36059629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.